Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 22.38% Profit

October 13, 2022
On August 4th, 2022, QuantWave's forecasting platform identified REGENERON PHARMACEUTICALS, INC. as a long opportunity with a price target forecast of $749.35. Today, on October 13th, the stock reached the predicted price, resulting in a profit of 22.38% for investors who followed the forecast.

This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The success of hitting the price target for REGENERON PHARMACEUTICALS, INC. demonstrates the platform's ability to provide valuable insights for investors looking to maximize their returns in the market.

Factors contributing to the stock's movement may include positive developments in the company's pipeline, market trends in the pharmaceutical sector, and overall economic conditions. Investors who capitalized on this forecast were able to benefit from these favorable conditions and generate significant profits.

QuantWave offers a wide range of stock predictions for users seeking to leverage market opportunities for potential gains. For investors interested in exploring the platform further, QuantSchool provides educational resources on how to utilize the forecasting system effectively to generate consistent income.
If you want to leave a comment, then you need Login or Register





Other data for REGN

Related data

REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....


REGNJune 27, 2025Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target  ~1 min.

Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin  ~1 min.

QuantWave's forecast signal for REGENERON PHARMACEUTICALS, INC. on December 13, 2024, predicted a short direction with a price of 728.18 $. On June 5, 2025, the stock reached the target price of 482....


REGNJune 5, 2025REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the forecast price target set by QuantWave, resulting in a profit of 32.0%. The forecast signal was issued on December 31, 2024, with a price of $709....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. (REGN) has successfully reached the price target forecast set by QuantWave, resulting in a profit of 27.18%....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 26.25%  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock recently achieved the price target forecast set by QuantWave on March 21, 2025. The forecast indicated a short direction, with the stock price at $657....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 27.18% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. (ticker: REGN) has successfully achieved the price target forecast set by QuantWave, realizing a profit of 27.18%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target with 20.42% Profit  ~2 min.

In a recent success story for QuantWave, the automated forecasting platform accurately predicted a short position for REGENERON PHARMACEUTICALS, INC....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 17.34% Profit  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast set by the QuantWave automated forecasting platform....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~1 min.

QuantWave, an automated forecasting platform, successfully predicted the short movement for REGENERON PHARMACEUTICALS, INC. with a price target of 572.6 $ on 2025-04-04, achieving a profit of 16.52%....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Hits 30.6% Profit Target as Forecasted by QuantWave  ~1 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 30.6%....


REGNJune 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 26.25% Profit: QuantWave's Success in Stock Prediction  ~2 min.

REGENERON PHARMACEUTICALS, INC. has recently reached the price target forecast set by QuantWave on June 4, 2025....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....